Furthermore, the frequency of oncogenic mutations was lower in MM than in CM: BRAF mutations were detected in 1649 (55.9%) patients with CM and in 7 of 122 patients with MM (5.8%; 5 V600E, 1 V600R, 1 V600K, and 1 “other”). This evidence concerns the gene BRAF and Miyoshi myopathy.